Glycine

Glycine

SCHEMBL4305397

CCCCCC(CC)OC(=O)/C=C/c1ccccc1OC.NCC(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 2/20 0.46
TFEB P19484 1/20 0.45
MAPT P10636 3/20 0.44
LMNA P02545 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
BCHE P06276 1/20 0.44
KDM4E B2RXH2 7/20 0.44
ALDH1A1 P00352 6/20 0.44
HPGD P15428 5/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 2/20 0.43
MAPK1 P28482 1/20 0.41
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LY96 Q9Y6Y9 1/20 0.40
MEN1 O00255 1/20 0.40
ALOX12 P18054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14562456 0.94 NFE2L2 (0.52) NFE2L2TFEBMAPTLMNANPC1
SCHEMBL62156 0.94 NFE2L2 (0.52) NFE2L2TFEBMAPTLMNANPC1
SCHEMBL31710835 0.94 NFE2L2 (0.52) NFE2L2TFEBMAPTLMNANPC1
SCHEMBL3008171 0.86 NFE2L2 (0.44) NFE2L2TFEBMAPTLMNANPC1
SCHEMBL887234 0.84 NFE2L2 (0.55) NFE2L2MAPTLMNANPC1RAB9A
SCHEMBL14645363 0.84 SMN1; SMN2 (0.48) NFE2L2TFEBMAPTLMNANPC1
SCHEMBL19579510 0.81 KDM4E (0.57) NFE2L2TFEBMAPTLMNANPC1
SCHEMBL19137920 0.80 NFKB1 (0.47) NFE2L2MAPTLMNANPC1RAB9A
SCHEMBL887236 0.80 MAPT (0.54) MAPTLMNANPC1RAB9AKDM4E
Amiloxate SCHEMBL128150 0.79 TDP1 (0.59) MAPTLMNAKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066407-A2 ALKYL BENZOATE MIXTURES Cognis IP Management GmbH (DE) 2009-06-10 EP disclosed
WO-2008037380-A2 ALKYL BENZOATE MIXTURES COGNIS IP MANAGEMENT GMBH (DE) 2008-04-03 WO disclosed